Brief: Transcode Therapeutics Announces Pricing Of $8 Mln Public Offering
Sept 25 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES PRICING OF $8 MILLION
PUBLIC
OFFERING
* PRICES UNDERWRITTEN PUBLIC OFFERING OF AN AGGREGATE 15.7
MILLION
SHARES AT A PUBLIC OFFERING PRICE OF $0.51 PER SHARE
Source text for Eikon: ID:nGNX7sTkgW
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors